Clinuvel Pharmaceuticals
CUVL · ASX
$4.94−$0.09 (−1.79%)TodayMarket closed ·
Prev close $5.03
Who owns CUVL
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 25.4% of CUVL’s shares.
- Wolgen (Philippe Jacques)6.8%
- Ender 1, L.L.C.5.1%
- Vanguard Investments Australia Ltd.5.0%
- Vanguard Capital Management, LLC2.5%
- Next 6 largest institutions6.0%
- All other shareholders74.6%
| Holder | Shares | % of shares |
|---|---|---|
| Wolgen (Philippe Jacques) | 3.43M | 6.78% |
| Ender 1, L.L.C. | 2.59M | 5.13% |
| Vanguard Investments Australia Ltd. | 2.51M | 4.97% |
| Vanguard Capital Management, LLC | 1.28M | 2.53% |
| Macquarie Investment Management Global Ltd. | 665.07K | 1.32% |
| Emilino Group Pty. Ltd. | 600.00K | 1.19% |
| Norges Bank Investment Management (NBIM) | 560.25K | 1.11% |
| DFA Australia Ltd. | 526.44K | 1.04% |
| Dimensional Fund Advisors, L.P. | 400.98K | 0.79% |
| Badcock (Mark Edwin) | 270.25K | 0.54% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Australian Shares Index Fund | 826.41K | 1.64% |
| Vanguard Total International Stock Index Fund | 567.87K | 1.12% |
| Statens Pensjonsfond Utland | 560.25K | 1.11% |
| Vanguard Developed Markets Index Fund | 415.31K | 0.82% |
| Macquarie Australian Small Companies | 292.96K | 0.58% |
Short interest
Settled Sep 30, 2026
- Shares short
- 12.06K
- Days to cover
- 1.08
- % of shares outstanding
- 0.02%
- Average daily volume
- 11.20K
- Change since last report
- −54.4%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.